San Marcos, Calif. – Three-time Olympian and Cal State San Marcos cross-country and track coach Steve Scott announced that he is undergoing proton therapy to treat prostate cancer — his second go-round with cancer.
The 58-year-old USA Track and Field Hall of Famer, who ran 136 under four minute miles in his career, made the announcement during the “Cougar Challenge” cross country meet at CSUSM’s Mangrum Track.
Scott chose to treat his “intermediate-risk” tumor with proton therapy– a form of radiation treatment that kills cancer cells while preserving healthy surrounding tissue — at the Scripps Proton Therapy Center in San Diego over more conventional X-ray or surgical options because of the proximity of the growth to the nerve bundle that controls his bowel and sexual functions and
worries about possible side effects, according to Scripps Health.
His father’s death from complications associated with X-ray radiation used to treat his prostate cancer raised concerns.
“The likely side effects involved in my case were unacceptable to me, so I began to look around to see if there were other options,” Scott said. “I was encouraged when I learned about proton therapy, which nobody had told me about. The more I read and spoke with others who had been treated with protons, the more I knew it was right for me.”
The location of Scripps Proton Therapy Center was also a deciding factor, he said, as he had been traveling north to Loma Linda. Scott is scheduled to finish an eight-week course of proton
treatment to eradicate the tumor at the end of this month, and officials said his coaching duties would not be affected.
Scott beat both testicular cancer and a pulmonary embolism two decades ago, U-T San Diego reported.
Dr. Carl Rossi of Scripps Proton Therapy Center has given the record setter’s a good to excellent prognosis, but he will require years of follow-up visits and monitoring, according to Scripps.
Scott said he decided to share his story to help raise awareness about the importance of early detection and the availability of proton therapy.